Detected ·
ONA Therapeutics
——
ONA Therapeutics, a clinical-stage oncology biotech developing precision-engineered antibody-drug conjugates (ADCs) for treatment-resistant cancers, raised $86.6M in Series B funding co-led by Columbus Venture Partners and Merieux Equity Partners.
- Website
- www.ona-therapeutics.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-06-04 08:09:27 UTC
- Signal ID
- a2fd732c-a6fc-4aeb-8dcf-32903533e433
As the API returns it
{
"id": "a2fd732c-a6fc-4aeb-8dcf-32903533e433",
"created_at": "2026-06-04T08:09:27.913228Z",
"company_name": "ONA Therapeutics",
"company_website_url": "www.ona-therapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/ona-therapeutics",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*ONA Therapeutics, a clinical-stage oncology biotech developing precision-engineered antibody-drug conjugates (ADCs) for treatment-resistant cancers, raised $86.6M in Series B funding co-led by Columbus Venture Partners and Merieux Equity Partners.*"
}